CompletedNot Applicable

Validity and Reliability of Arabic Version of Extended Aberdeen Spine Pain Scale

Egypt300 participantsStarted 2025-09-15

Plain-language summary

The goal of this observational study is to determine whether the Arabic version of the Extended Aberdeen Spine Pain Scale (EASPS) is a valid and reliable tool for assessing spine-related pain and functional disability in Arabic-speaking adults with nonspecific spinal pain. The main questions it aims to answer are: * Is the Arabic version of the EASPS a valid instrument for evaluating spine-related pain and disability among Arabic-speaking patients? * Is the Arabic version of the EASPS a reliable instrument with acceptable internal consistency and test-retest reliability? Participants will: * Complete the Arabic version of the Extended Aberdeen Spine Pain Scale (EASPS). * Complete the Arabic version of the Short Form-36 (SF-36) questionnaire to assess construct validity. * Participate in the cultural adaptation and validation process of the Arabic EASPS. * A subgroup of participants will complete the Arabic EASPS again after 7 days to assess test-retest reliability.

Who can participate

Age range

18 Years – 45 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18-45 years. * Both sexes. * Diagnosed with nonspecific spinal pain (cervical, thoracic, or lumbar). * Arabic is a primary spoken and written language. * Ability to provide informed consent. Inclusion criteria for experts: * Their experiences aren't less than ten years or at least master's degree in physical therapy. * Major part of their work is with the Arabic population. * They are fluent in Arabic and English language. * Both genders were included. Exclusion Criteria: * History of spinal surgery. * Neurological deficits or serious pathology (e.g., cancer, infection). * Cognitive impairment or psychiatric conditions preventing questionnaire completion. * Undergoing active treatment changes during test-retest interval.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Arabic Version of the Extended Aberdeen Spine Pain Scale (EASPS)

Timeframe: Baseline and 7 Days

Trial details

NCT IDNCT07671196

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-04-01

View on ClinicalTrials.gov More Nonspecific Spinal Pain (Including Cervical, Thoracic, and Lumbar Spinal Pain) trials